The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways
Corona Virus Disease 2019 (COVID-19) has brought the new challenges to scientific research. Isodon suzhouensis has good anti-inflammatory and antioxidant stress effects, which is considered as a potential treatment for COVID-19. The possibility for the treatment of COVID-19 with I. suzhouensis and i...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tsinghua University Press
2024-11-01
|
| Series: | Food Science and Human Wellness |
| Subjects: | |
| Online Access: | https://www.sciopen.com/article/10.26599/FSHW.2023.9250011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841550118236454912 |
|---|---|
| author | Hong Duan Wei Wang Shu Li Han Li Ghulam Jilany Khan Yong Ma Fawang Liu Kefeng Zhai Henggui Hu Zhaojun Wei |
| author_facet | Hong Duan Wei Wang Shu Li Han Li Ghulam Jilany Khan Yong Ma Fawang Liu Kefeng Zhai Henggui Hu Zhaojun Wei |
| author_sort | Hong Duan |
| collection | DOAJ |
| description | Corona Virus Disease 2019 (COVID-19) has brought the new challenges to scientific research. Isodon suzhouensis has good anti-inflammatory and antioxidant stress effects, which is considered as a potential treatment for COVID-19. The possibility for the treatment of COVID-19 with I. suzhouensis and its potential mechanism of action were explored by employing molecular docking and network pharmacology. Network pharmacology and molecular docking were used to screen drug targets, and lipopolysaccharide (LPS) induced RAW264.7 and NR8383 cells inflammation model was used for experimental verification. Collectively a total of 209 possible linkages against 18 chemical components from I. suzhouensis and 1194 COVID-19 related targets were selected. Among these, 164 common targets were obtained from the intersection of I. suzhouensis and COVID-19. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enriched 582 function targets and 87 target proteins pathways, respectively. The results from molecular docking studies revealed that rutin, vitexin, isoquercitrin and quercetin had significant binding ability with 3 chymotrypsin like protease (3CLpro) and angiotensin converting enzyme 2 (ACE2). In vitro studies showed that I. suzhouensis extract (ISE) may inhibit the activation of PI3K/Akt pathway and the expression level of downstream proinflammatory factors by inhibiting the activation of epidermal growth factor receptor (EGFR) in RAW264.7 cells induced by LPS. In addition, ISE was able to inhibit the activation of TLR4/NF-κB signaling pathway in NR8383 cells exposed to LPS. Overall, the network pharmacology and in vitro studies conclude that active components from I. suzhouensis have strong therapeutic potential against COVID-19 through multi-target, multi-pathway dimensions and can be a promising candidate against COVID-19. |
| format | Article |
| id | doaj-art-87d13e210df145c69fb010b2505a3ad8 |
| institution | Kabale University |
| issn | 2097-0765 2213-4530 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Tsinghua University Press |
| record_format | Article |
| series | Food Science and Human Wellness |
| spelling | doaj-art-87d13e210df145c69fb010b2505a3ad82025-01-10T06:57:02ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302024-11-011363245325510.26599/FSHW.2023.9250011The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathwaysHong Duan0Wei Wang1Shu Li2Han Li3Ghulam Jilany Khan4Yong Ma5Fawang Liu6Kefeng Zhai7Henggui Hu8Zhaojun Wei9School of Biological and Food Engineering, Engineering Research Center for Development and High Value Utilization of Genuine Medicinal Materials in North Anhui Province, Suzhou University, Suzhou 234000, ChinaSchool of Biological and Food Engineering, Engineering Research Center for Development and High Value Utilization of Genuine Medicinal Materials in North Anhui Province, Suzhou University, Suzhou 234000, ChinaSchool of Biological and Food Engineering, Engineering Research Center for Development and High Value Utilization of Genuine Medicinal Materials in North Anhui Province, Suzhou University, Suzhou 234000, ChinaSchool of Biological and Food Engineering, Engineering Research Center for Development and High Value Utilization of Genuine Medicinal Materials in North Anhui Province, Suzhou University, Suzhou 234000, ChinaDepartment of Pharmacology and Therapeutics, Faculty of Pharmacy, University of Central Punjab, Lahore 54000, PakistanSuzhou YiFan Pharmaceutical Co., Ltd., Suzhou 234000, ChinaSchool of Biological and Food Engineering, Engineering Research Center for Development and High Value Utilization of Genuine Medicinal Materials in North Anhui Province, Suzhou University, Suzhou 234000, ChinaSchool of Biological and Food Engineering, Engineering Research Center for Development and High Value Utilization of Genuine Medicinal Materials in North Anhui Province, Suzhou University, Suzhou 234000, ChinaGeneral Clinical Research Center, Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou 234000, ChinaSchool of Biological Science and Engineering, North Minzu University, Yinchuan 750021, ChinaCorona Virus Disease 2019 (COVID-19) has brought the new challenges to scientific research. Isodon suzhouensis has good anti-inflammatory and antioxidant stress effects, which is considered as a potential treatment for COVID-19. The possibility for the treatment of COVID-19 with I. suzhouensis and its potential mechanism of action were explored by employing molecular docking and network pharmacology. Network pharmacology and molecular docking were used to screen drug targets, and lipopolysaccharide (LPS) induced RAW264.7 and NR8383 cells inflammation model was used for experimental verification. Collectively a total of 209 possible linkages against 18 chemical components from I. suzhouensis and 1194 COVID-19 related targets were selected. Among these, 164 common targets were obtained from the intersection of I. suzhouensis and COVID-19. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enriched 582 function targets and 87 target proteins pathways, respectively. The results from molecular docking studies revealed that rutin, vitexin, isoquercitrin and quercetin had significant binding ability with 3 chymotrypsin like protease (3CLpro) and angiotensin converting enzyme 2 (ACE2). In vitro studies showed that I. suzhouensis extract (ISE) may inhibit the activation of PI3K/Akt pathway and the expression level of downstream proinflammatory factors by inhibiting the activation of epidermal growth factor receptor (EGFR) in RAW264.7 cells induced by LPS. In addition, ISE was able to inhibit the activation of TLR4/NF-κB signaling pathway in NR8383 cells exposed to LPS. Overall, the network pharmacology and in vitro studies conclude that active components from I. suzhouensis have strong therapeutic potential against COVID-19 through multi-target, multi-pathway dimensions and can be a promising candidate against COVID-19.https://www.sciopen.com/article/10.26599/FSHW.2023.9250011isodon suzhouensiscovid-19network pharmacologytlr4/nf-κb pathwayepidermal growth factor receptorpi3k/akt pathway |
| spellingShingle | Hong Duan Wei Wang Shu Li Han Li Ghulam Jilany Khan Yong Ma Fawang Liu Kefeng Zhai Henggui Hu Zhaojun Wei The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways Food Science and Human Wellness isodon suzhouensis covid-19 network pharmacology tlr4/nf-κb pathway epidermal growth factor receptor pi3k/akt pathway |
| title | The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways |
| title_full | The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways |
| title_fullStr | The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways |
| title_full_unstemmed | The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways |
| title_short | The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways |
| title_sort | potential mechanism of isodon suzhouensis against covid 19 via egfr tlr4 pathways |
| topic | isodon suzhouensis covid-19 network pharmacology tlr4/nf-κb pathway epidermal growth factor receptor pi3k/akt pathway |
| url | https://www.sciopen.com/article/10.26599/FSHW.2023.9250011 |
| work_keys_str_mv | AT hongduan thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT weiwang thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT shuli thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT hanli thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT ghulamjilanykhan thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT yongma thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT fawangliu thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT kefengzhai thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT hengguihu thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT zhaojunwei thepotentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT hongduan potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT weiwang potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT shuli potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT hanli potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT ghulamjilanykhan potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT yongma potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT fawangliu potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT kefengzhai potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT hengguihu potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways AT zhaojunwei potentialmechanismofisodonsuzhouensisagainstcovid19viaegfrtlr4pathways |